Pfizer asks US officials to OK promising COVID-19 pill - Albuquerque Journal

Pfizer asks US officials to OK promising COVID-19 pill

WASHINGTON — Pfizer asked U.S. regulators Tuesday to authorize its experimental pill for COVID-19, setting the stage for a likely launch this winter of a promising treatment that can be taken at home.

The company’s filing comes as new infections are rising once again in the United States, driven mainly by hot spots in states where colder weather is driving more Americans indoors.

Pfizer’s pill has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections. The Food and Drug Administration is already reviewing a competing pill from Merck and several smaller drugmakers are also expected to seek authorization for their own antiviral pills in the coming months.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application,” said Pfizer CEO Albert Bourla, in a statement.

Specifically, Pfizer wants the drug available for adults who have mild-to-moderate COVID-19 infections and are at risk of becoming seriously ill. That’s similar to how other drugs are currently used to treat the disease. But all FDA-authorized COVID-19 treatments require an IV or injection given by a health professional at a hospital or clinic.

The FDA is holding a public meeting on the Merck pill later this month to get the opinion of outside experts before making its decision. The agency isn’t required to convene such meetings and it’s not yet known whether Pfizer’s drug will undergo a similar public review.

Some experts predict COVID-19 treatments eventually will be combined to better protect against the worst effects of the virus.

Pfizer reported earlier this month that its pill cut hospitalizations and deaths by 89% among high-risk adults who had early symptoms of COVID-19. The company studied its pill in people who were unvaccinated and faced the worst risks from the virus due to age or health problems, such as obesity. If authorized, the FDA will have to weigh making the pill available for vaccinated people dealing with breakthrough infections, since they weren’t part of the initial tests.

For best results, patients need to start taking the pills within three days of symptoms, underscoring the need for speedy testing and diagnosis. That could be a challenge if another COVID-19 surge leads to testing delays and shortages seen last winter.

Pfizer’s drug is part of a decades-old family of antiviral drugs known as protease inhibitors, which revolutionized the treatment of HIV and hepatitis C. The drugs block a key enzyme which viruses need to multiply in the human body. That’s different than the Merck pill, which causes tiny mutations in the coronavirus until the point that it can’t reproduce itself.

On Tuesday, Pfizer signed a deal a with U.N.-backed group to allow generic drugmakers to produce low-cost versions of the pill for certain countries. Merck has a similar deal for its pill, which was authorized in Britain earlier this month.

The U.S. has approved one other antiviral drug for COVID-19, remdesivir, and authorized three antibody therapies that help the immune system fight the virus. But they usually have to be given via time-consuming infusions by health professionals, and limited supplies were strained by the last surge of the delta variant.

The U.S. government has already committed to purchasing Merck’s pill. Federal authorities were in negotiations with Pfizer to buy millions of doses of its pill, according to an official familiar with the matter.

___

AP reporter Zeke Miller in Washington contributed.

___

Follow Matthew Perrone on Twitter: @AP_FDAwriter

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.


Albuquerque Journal and its reporters are committed to telling the stories of our community.

• Do you have a question you want someone to try to answer for you? Do you have a bright spot you want to share?
   We want to hear from you. Please email yourstory@abqjournal.com

Nativo Sponsored Content

taboola desktop

MORE ARTICLES LIKE THIS

1
Permanent funds generate record-high $1.3B for NM
From the newspaper
Distributions go toward public schools, hospitals Distributions go toward public schools, hospitals
2
Legislator treated at hospital after crash
ABQnews Seeker
State Rep. Roger Montoya, D-Velarde, was ... State Rep. Roger Montoya, D-Velarde, was rescued from a snowy road Wednesday morning after a car crash trapped him in his vehicle. In written ...
3
New Mexico officials expect to omicron surge will peak ...
ABQnews Seeker
New Mexico health officials said Wednesday ... New Mexico health officials said Wednesday that modeling suggests the surge in COVID-19 infections is expected to peak within the coming week. State Health ...
4
Biden nominates new US Attorney for NM
ABQnews Seeker
Uballez is currently a federal prosecutor ... Uballez is currently a federal prosecutor in the state
5
Bernalillo County seeks help at the jail
ABQnews Seeker
Commission approves emergency resolution to deal ... Commission approves emergency resolution to deal with staffing shortage
6
Gov. begins push on hydrogen bill
ABQnews Seeker
Proposal incentivizes industry hubs in NM; ... Proposal incentivizes industry hubs in NM; environmentalists still opposed
7
18-year-old charged after robbery, shootout at massage parlor leaves ...
ABQnews Seeker
Detectives have arrested a young man ... Detectives have arrested a young man who they say robbed a massage parlor with an accomplice and killed the owner in a gunfight Monday ...
8
ABQ named No. 1 for moviemakers for fourth year ...
Albuquerque News
Albuquerque is No. 1, again — ... Albuquerque is No. 1, again — for the fourth consecutive year. The city topped MovieMaker's 2022 'Best Places to Live and Work as a ...
9
NM's Great Resigners: Former tattoo artist bakes up a ...
ABQnews Seeker
Medlock started making pizzas out of ... Medlock started making pizzas out of his garage during the pandemic
10
Petroglyphs defaced outside Santa Fe
ABQnews Seeker
La Cieneguilla site dates back 8,000 ... La Cieneguilla site dates back 8,000 years; 10 works damaged